SCINTILLATION NANOTECHNOLOGIES INC

Vail, AZ · Biotech · Private

Core-shell nanomaterials for real-time detection of radioisotope-labeled biomolecules in aqueous samples

Grants
$1.2M
6 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Sensitive Nanoscintillators for Multiplexed Detection of Radioisotopes$224,700
Federal grantDepartment of Health and Human Services · Phase I · Membrane Functionalized Nanoparticles for Ligand Screening$241,178
Federal grantDepartment of Health and Human Services · Phase I · Membrane Functionalized Nanoparticles for Ligand Screening$241,178
Federal grantDepartment of Health and Human Services · Phase I · Nanomaterial Radioisotope Detectors for Intracellular Measurements$149,800
Federal grantDepartment of Health and Human Services · Phase I · Nanomaterial Radioisotope Detectors for Intracellular Measurements$149,800
Federal grantDepartment of Health and Human Services · Phase I · Nanoparticle Radioassay for Proteins in Native Membranes$210,469
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2717OnRamp Digital, Inc.—$360K
2718Mendra——
2719GLYTR THERAPEUTICS, INC.——
2720SCINTILLATION NANOTECHNOLOGIES INC——
2721COMPUTCHEM LLC——
2722MIDWEST BIOPROCESSING CENTER LLC——
2723Accuronix Therapeutics Inc——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.